Patent References 3551556 3911099 Method comprising transdermal and buccal treatment of angina Sustained-release preparation applicable to mucous membrane in oral cavity Patent #: 4740365 InventorsAssigneeApplicationNo. 202662 filed on 06/03/1988US Classes:424/435, Mouth424/434, Mucosal (e.g., nasal, etc.)424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/448, Pressure sensitive adhesive means424/484, Matrices424/486, Synthetic polymer514/178, Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/182, Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/224.2, Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.)514/356, C=O in a C(=O)O group (e.g., nicotinic acid, etc.)514/653Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)ExaminersPrimary: Page, Thurman K.Assistant: Spear, James M. Attorney, Agent or FirmForeign Patent References
International ClassesA61F 013/00A61K 009/26 AbstractA mucoadhesive carried suitable for a therapeutic agent is disclosed. This carrier allows controlled release of the therapeutic agent via mucosal tissue. The mucoadhesive carrier comprises a Monolithic polymer matrix that is anhydrous but hydratable, and amorphous fumed silica. The silica enhances the mucoadhesive properties of the carrier. An optional water-insoluble barrier film or layer can be secured to the polymer matrix to provide a non-adhering face. | |